Northern Trust’s OnKure Therapeutics, Inc. Class A Common Stock OKUR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53.8K | Buy |
22,510
+3,333
| +17% | +$7.97K | ﹤0.01% | 4218 |
|
|
2025
Q1 | $82.5K | Hold |
19,177
| – | – | ﹤0.01% | 4152 |
|
|
2024
Q4 | $165K | Buy |
19,177
+14,776
| +336% | +$127K | ﹤0.01% | 4040 |
|
|
2024
Q3 | $74.8K | Sell |
4,401
-7,385
| -63% | -$126K | ﹤0.01% | 4125 |
|
|
2024
Q2 | $178K | Buy |
11,786
+572
| +5% | +$8.64K | ﹤0.01% | 3898 |
|
|
2024
Q1 | $186K | Sell |
11,214
-450
| -4% | -$7.47K | ﹤0.01% | 3920 |
|
|
2023
Q4 | $187K | Sell |
11,664
-362
| -3% | -$5.79K | ﹤0.01% | 3918 |
|
|
2023
Q3 | $916K | Buy |
12,026
+2,018
| +20% | +$154K | ﹤0.01% | 3330 |
|
|
2023
Q2 | $657K | Buy |
10,008
+8,505
| +566% | +$558K | ﹤0.01% | 3471 |
|
|
2023
Q1 | $89.9K | Buy |
1,503
+312
| +26% | +$18.7K | ﹤0.01% | 4108 |
|
|
2022
Q4 | $27.7K | Hold |
1,191
| – | – | ﹤0.01% | 4415 |
|
|
2022
Q3 | $40K | Hold |
1,191
| – | – | ﹤0.01% | 4386 |
|
|
2022
Q2 | $31K | Sell |
1,191
-5,651
| -83% | -$147K | ﹤0.01% | 4548 |
|
|
2022
Q1 | $201K | Buy |
6,842
+487
| +8% | +$14.3K | ﹤0.01% | 4128 |
|
|
2021
Q4 | $544K | Buy |
6,355
+452
| +8% | +$38.7K | ﹤0.01% | 3776 |
|
|
2021
Q3 | $439K | Sell |
5,903
-942
| -14% | -$70.1K | ﹤0.01% | 3813 |
|
|
2021
Q2 | $639K | Buy |
+6,845
| New | +$639K | ﹤0.01% | 3636 |
|